Home›Search›Translational Lung Cancer Research

Translational Lung Cancer Research

AME Publishing Company · Hong Kong · Est. 1929

ISSN2226-4477

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.987

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.985

Total Worksi

2,597

Total Citationsi

39,789

2yr Mean Citednessi

1.94

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Respiratory System.

General Information

Country / RegionHong Kong

Primary LanguageEnglish

1st Year Published1929

Annual Volume~ 333 articles / year

StatusActive (last: 2026)

Total Publications2,597

Publisher OrgAME Publishing Company

OA Since2018

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

AME Publishing Company

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2226-4477

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

189

5.5k

2019

302

6.6k

2020

389

8.3k

2021

234

3.2k

2022

244

1.9k

2023

324

1.3k

2024

431

694

2025

187

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Subject Classification

Web of Science Categories

OncologyRespiratory System

Scopus Categories

Oncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingCancer Genomics and DiagnosticsPleural and Pulmonary DiseasesFerroptosis and cancer prognosisOccupational and environmental lung diseasesHepatocellular Carcinoma Treatment and Prognosis

Frequently asked questions about Translational Lung Cancer Research

Is Translational Lung Cancer Research a predatory journal?

PubScope has no integrity flags on record for Translational Lung Cancer Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Translational Lung Cancer Research?

Translational Lung Cancer Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.94.

Is Translational Lung Cancer Research indexed in Scopus and Web of Science?

Translational Lung Cancer Research is indexed in Web of Science, Scopus.

What is the aims and scope of Translational Lung Cancer Research?